Titration to High-Intensity Statin Therapy Following Acute Myocardial Infarction in Patients With and Without Diabetes Mellitus

[1]  Peter L Duffy,et al.  Sex differences in the effect of diabetes mellitus on platelet reactivity and coronary thrombosis: From the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents (ADAPT-DES) study. , 2017, International journal of cardiology.

[2]  T. Brown,et al.  Trends in Use of High-Intensity Statin Therapy After Myocardial Infarction, 2011 to 2014. , 2017, Journal of the American College of Cardiology.

[3]  M. Banach,et al.  Statin Intolerance and Risk of Coronary Heart Events and All-Cause Mortality Following Myocardial Infarction. , 2017, Journal of the American College of Cardiology.

[4]  G. Stone,et al.  Safety and Efficacy of Bivalirudin in Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: From the REPLACE-2, ACUITY and HORIZONS-AMI Trials. , 2016, The American journal of cardiology.

[5]  Laurie Quinn,et al.  Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association. , 2015, Circulation.

[6]  Barry J. Davis,et al.  Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials , 2015, The Lancet.

[7]  B. Davis,et al.  The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials , 2015, European heart journal.

[8]  T. Brown,et al.  Underutilization of high-intensity statin therapy after hospitalization for coronary heart disease. , 2015, Journal of the American College of Cardiology.

[9]  Jennifer G. Robinson,et al.  2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.

[10]  J. Spertus,et al.  Patterns and predictors of intensive statin therapy among patients with diabetes mellitus after acute myocardial infarction. , 2014, The American journal of cardiology.

[11]  J. Spertus,et al.  Beyond medication prescription as performance measures: optimal secondary prevention medication dosing after acute myocardial infarction. , 2013, Journal of the American College of Cardiology.

[12]  K. Alexander,et al.  Use of aldosterone antagonists at discharge after myocardial infarction: results from the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network (ACTION) Registry-Get with the Guidelines (GWTG). , 2013, American heart journal.

[13]  Jerry Q. Cheng,et al.  Meta-analysis of statin effects in women versus men. , 2012, Journal of the American College of Cardiology.

[14]  R. Gillett,et al.  Considerations for safe use of statins: liver enzyme abnormalities and muscle toxicity. , 2011, American family physician.

[15]  Deepak L. Bhatt,et al.  Use of intensive lipid-lowering therapy in patients hospitalized with acute coronary syndrome: an analysis of 65,396 hospitalizations from 344 hospitals participating in Get With The Guidelines (GWTG). , 2010, American heart journal.

[16]  J. Armitage,et al.  The safety of statins in clinical practice , 2007, The Lancet.

[17]  J. L. Wall,et al.  Total and Component Health Care Costs in a Non-Medicare HMO Population of Patients With and Without Type 2 Diabetes and With and Without Macrovascular Disease , 2006, Journal of managed care pharmacy : JMCP.

[18]  A. Gawlinski,et al.  Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP). , 2001, The American journal of cardiology.

[19]  M. Laakso,et al.  Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. , 1998, The New England journal of medicine.

[20]  Jennifer G. Robinson,et al.  Reprint: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults. , 2013, Journal of the American Pharmacists Association : JAPhA.

[21]  J. Wofford.  Clinical inertia. , 2002, Annals of internal medicine.

[22]  William Branch,et al.  Clinical Inertia , 2001, Annals of Internal Medicine.